1. Home
  2. SCOR vs NRSN Comparison

SCOR vs NRSN Comparison

Compare SCOR & NRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo comScore Inc.

SCOR

comScore Inc.

HOLD

Current Price

$7.08

Market Cap

32.8M

ML Signal

HOLD

Logo NeuroSense Therapeutics Ltd.

NRSN

NeuroSense Therapeutics Ltd.

HOLD

Current Price

$0.78

Market Cap

28.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCOR
NRSN
Founded
1999
2017
Country
United States
Israel
Employees
N/A
15
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
32.8M
28.4M
IPO Year
2007
N/A

Fundamental Metrics

Financial Performance
Metric
SCOR
NRSN
Price
$7.08
$0.78
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$8.50
AVG Volume (30 Days)
15.1K
153.2K
Earning Date
03-17-2026
03-20-2026
Dividend Yield
N/A
N/A
EPS Growth
21.88
N/A
EPS
N/A
N/A
Revenue
$403,549,000.00
N/A
Revenue This Year
$2.01
N/A
Revenue Next Year
$1.57
N/A
P/E Ratio
N/A
N/A
Revenue Growth
1.02
N/A
52 Week Low
$4.39
$0.68
52 Week High
$10.18
$2.60

Technical Indicators

Market Signals
Indicator
SCOR
NRSN
Relative Strength Index (RSI) 49.93 39.05
Support Level $7.09 $0.68
Resistance Level $8.27 $1.30
Average True Range (ATR) 0.57 0.07
MACD 0.05 -0.01
Stochastic Oscillator 58.34 11.94

Price Performance

Historical Comparison
SCOR
NRSN

About SCOR comScore Inc.

comScore Inc is a United States-based information and analytics company that measures advertising, content, and the consumer audiences of each across media platforms. The platforms it measures include televisions, mobile devices, computers, tablets, CTV devices, and movie theaters. The company generates almost all its revenue from the United States, followed by Europe, Latin America, Canada, and other regions. It provides solutions for the automotive, digital media, financial services, pharmaceutical, retail, technology, travel, and other industries.

About NRSN NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.

Share on Social Networks: